D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 65 Citations 19,123 158 World Ranking 808 National Ranking 40
Medicine D-index 79 Citations 28,135 261 World Ranking 10022 National Ranking 320

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Virus

Genotype, Internal medicine, Immunology, Virology and Genotyping are his primary areas of study. The various areas that he examines in his Genotype study include Molecular biology, Helicobacter pylori and Mass screening. His biological study spans a wide range of topics, including Gastroenterology, Oncology and Hepatitis C virus.

His Immunology study combines topics from a wide range of disciplines, such as Prevalence, Disease, HPV infection and Papillomavirus Vaccines. His study on HPV infection is covered under Cervical cancer. Wim Quint has researched Virology in several fields, including Antibody and Polymerase chain reaction.

His most cited work include:

  • Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study (1555 citations)
  • Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial (1474 citations)
  • Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial (1140 citations)

What are the main themes of his work throughout his whole career to date?

Wim Quint mainly investigates Internal medicine, Cervical cancer, Virology, Genotype and Pathology. His work deals with themes such as Oncology and Vaccination, which intersect with Internal medicine. The study incorporates disciplines such as Adenocarcinoma, Gynecology and Cervix in addition to Cervical cancer.

His Virology research includes themes of Antibody and Polymerase chain reaction. His work on Genotyping is typically connected to CagA as part of general Genotype study, connecting several disciplines of science. His HPV infection research incorporates elements of Sex organ, Immunology and Cohort.

He most often published in these fields:

  • Internal medicine (31.14%)
  • Cervical cancer (24.85%)
  • Virology (23.95%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (31.14%)
  • Oncology (16.17%)
  • Cervical cancer (24.85%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Oncology, Cervical cancer, Pathology and Human papillomavirus. His Internal medicine research is multidisciplinary, incorporating perspectives in Cytology and Vaccination. His work carried out in the field of Oncology brings together such families of science as Logistic regression, Abnormal cytology, Genotyping, Cervical cancer screening and Invasive cervical cancer.

The Cervical cancer study combines topics in areas such as Methylation, Genotype and Adenocarcinoma. His work on Hpv genotypes as part of general Genotype study is frequently linked to Attribution, bridging the gap between disciplines. His Human papillomavirus research is multidisciplinary, relying on both Immunology, Pathogenesis, Penile Intraepithelial Neoplasia, Hpv types and Human leukocyte antigen.

Between 2017 and 2021, his most popular works were:

  • Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial (43 citations)
  • Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study. (34 citations)
  • Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58 (30 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Virus

His primary scientific interests are in Internal medicine, Cervical cancer, Pathology, Oncology and Cervical intraepithelial neoplasia. His work on Cohort as part of general Internal medicine research is frequently linked to Dialister, bridging the gap between disciplines. His Cervical cancer research incorporates themes from Grading, P16 ink4a, Genotype and Human papillomavirus.

Wim Quint usually deals with Genotype and limits it to topics linked to DNA sequencing and Genotyping. His biological study spans a wide range of topics, including Cancer and Methylation. His Cervical intraepithelial neoplasia research is multidisciplinary, incorporating elements of Ki-67, Scoring system, Nuclear medicine and Reproducibility.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron Gale Ferris.
The Lancet (2004)

2220 Citations

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)

2167 Citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud.
The Lancet (2007)

1784 Citations

The biology and life-cycle of human papillomaviruses.

John Doorbar;Wim Quint;Lawrence Banks;Ignacio G. Bravo.
Vaccine (2012)

1258 Citations

Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori

Leen–Jan van Doorn;Céu Figueiredo;Ricardo Sanna;Anton Plaisier.
Gastroenterology (1998)

779 Citations

Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma

Céu Figueiredo;José Carlos Machado;Paul Pharoah;Raquel Seruca.
Journal of the National Cancer Institute (2002)

756 Citations

Comprehensive control of human papillomavirus infections and related diseases.

F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Vaccine (2013)

603 Citations

Geographic distribution of vacA allelic types of Helicobacter pylori.

Leen–Jan Van Doorn;Céu Figueiredo;Francis Mégraud;Salvador Pena.
Gastroenterology (1999)

535 Citations

GENUS AND SPECIES- SPECIFIC IDENTIFICATION OF MYCOPLASMAS BY 16S RRNA AMPLIFICATION

F.J.M. van Kuppeveld;J.T.M. van der Logt;A.F. Angulo;M.J. van Zoest.
Applied and Environmental Microbiology (1992)

517 Citations

Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis.

Mark A. Rubin;Bernard Kleter;Ming Zhou;Gustavo Ayala.
American Journal of Pathology (2001)

498 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Wim Quint

Suzanne M. Garland

Suzanne M. Garland

Royal Women's Hospital

Publications: 168

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 164

Michael Pawlita

Michael Pawlita

German Cancer Research Center

Publications: 130

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 128

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 109

Tim Waterboer

Tim Waterboer

German Cancer Research Center

Publications: 108

Massimo Tommasino

Massimo Tommasino

International Agency For Research On Cancer

Publications: 104

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 104

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 103

Luisa L. Villa

Luisa L. Villa

Universidade de São Paulo

Publications: 103

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 100

Peter J.F. Snijders

Peter J.F. Snijders

Vrije Universiteit Amsterdam

Publications: 85

Silvia de Sanjosé

Silvia de Sanjosé

University of Barcelona

Publications: 83

Timothy L. Cover

Timothy L. Cover

Veterans Health Administration

Publications: 82

Yoshio Yamaoka

Yoshio Yamaoka

Oita University

Publications: 82

Willem J. G. Melchers

Willem J. G. Melchers

Radboud University Nijmegen

Publications: 76

Trending Scientists

Timothy Baldwin

Timothy Baldwin

University of Melbourne

Wenliang Du

Wenliang Du

Syracuse University

Lubomir Bourdev

Lubomir Bourdev

WaveOne, Inc.

Wei Lei

Wei Lei

Southeast University

Linda See

Linda See

International Institute for Applied Systems Analysis

Julian F. Tyson

Julian F. Tyson

University of Massachusetts Amherst

Pengjian Zuo

Pengjian Zuo

Harbin Institute of Technology

Alexander Bismarck

Alexander Bismarck

University of Vienna

Simon R. Thorrold

Simon R. Thorrold

Woods Hole Oceanographic Institution

Ramadan I. Sha'afi

Ramadan I. Sha'afi

University of Connecticut Health Center

Mark Viney

Mark Viney

University of Bristol

David C. Goodrich

David C. Goodrich

Agricultural Research Service

Tracy L. Spinrad

Tracy L. Spinrad

Arizona State University

Zarko Alfirevic

Zarko Alfirevic

University of Liverpool

Maurizio Margaglione

Maurizio Margaglione

University of Foggia

Something went wrong. Please try again later.